drugset / Trial / NCT03740334
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This research study is evaluating a drug called ribociclib (LEE011) given in combination with everolimus and other standard of care chemotherapy drugs as a possible treatment for relapsed or refractory ALL. The names of the drugs involved in this study are: * ribociclib * everolimus * dexamethasone
Timeline
- Start
- 2019-01-30
- Primary completion
- 2023-03-04
- Completion
- 2026-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |
| Subject | Ribociclib | Small molecule | — | — |
| Background | Dexamethasone | Small molecule | — | Intravenous |